News

Optimind Pharma Closes Second Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - July 29, 2024) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed…

1 year ago

NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE

HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare…

1 year ago

AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics

EYSINS, Switzerland, July 29, 2024 /PRNewswire/ -- AliveDx ("Company") is proud to announce it has received IVDR CE mark for…

1 year ago

NUS researchers develop a novel technique to fabricate three-dimensional circuits for advanced electronics

CHARM3D paves the way for the efficient printing of free-standing 3D structures that offer high electrical conductivity, self-healing capabilities and recyclability…

1 year ago

Hardinge Takes Strategic Action to Facilitate Sale Process and Continue Global Industry Leadership on Reinforced Financial Foundation

Enters into agreement in principle on asset purchase agreement with an affiliate of Centre Lane Partners for sale of substantially…

1 year ago

Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation

Presentation at Macrophage-Directed Therapies Summit LONDON, UNITED KINGDOM / ACCESSWIRE / July 29, 2024 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals"…

1 year ago

International OCD Foundation Honors Reality Star Scheana Shay for Raising OCD Awareness

ORLANDO, FL / ACCESSWIRE / July 28, 2024 / Reality television sensation Scheana Shay received international accolades Saturday, July 27,…

1 year ago

Regeneration Biomedical to Present Data on First Two Subjects in a Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brains of Patients with Alzheimer’s Disease

Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the…

1 year ago

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel…

1 year ago

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated.VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics…

1 year ago